3-(2,2,2-Trifluoroethyl)azetidine hydrochloride, 95%, 5g

2-Bromo-1-(1-methyl-1H-imidazol-2-yl)ethanone, 95.0%, 250mg

5-Fluoro-2-(piperidin-4-yloxy)pyrimidinehydrochloride, 1g

4-methyl-2-phenyl-5-pyrimidinecarboxylic acid, 95.0%, 2.5g

Tartrazine (CI 19140), 25 g, glass packaging

1-(dibromomethyl)-4-nitrobenzene, 25g

[4,4'-Bipyridine]-2,2'-dicarboxylic acid, 95%, 100mg

N~1~,N~1~,2-Trimethyl-1,2-propanediamine dihydrochloride, 95.0%, 5g

4,4-Difluorocyclohexanecarbonitrile, 95.0%, 500mg

2-sec-Butylcyclohexanone (mixture of isomers)>98.0%(GC)25g

4-Amino-2-fluoro-N-methylbenzamide, 95.0%, 5g

Trifluoroacetaldehyde monohydrate, 72% aqueous solution, 1g

4,4'-(Diazene-1,2-diyl)bis(4-cyanopentanoic acid) (contains 13-18% water), 99.0%, 25g